Amerigo Scientific, a U.S.-based distributor of life science products, recently announced the release of high-purity, premium-quality induced pluripotent stem cell (iPSC)-derived cells and engineered reporter iPSC-derived cells. These products aim to provide robust research tools for disease mechanism exploration, high-throughput drug screening, and innovative cell therapy development across the life science industry.
Induced pluripotent stem cells represent a revolutionary advancement in stem cell research. Unlike embryonic stem cells, iPSCs are generated by genetically reprogramming terminally differentiated somatic cells, eliminating reliance on fertilized eggs and resolving ethical dilemmas associated with embryonic stem cell use. Derived from adult tissue cells such as adipose stem cells, amniotic cells, dental pulp cells, and skin fibroblasts, iPSCs can differentiate into diverse cell types, supporting versatile biomedical research.
Cells differentiated from iPSCs exhibit high consistency with in vivo and primary cells in transcription, cellular structure, and biological functions, while maintaining stable genetic information. Compared with primary tissue-derived cells, iPSC-derived cells are easier to acquire, culture, and maintain. They are also amenable to genome editing technologies like CRISPR-Cas9 and TALENs, enabling flexible genetic modification for customized research. Patient-specific iPSCs retain disease-related phenotypic characteristics, making them ideal for studying inherited and acquired diseases. Human iPSCs carrying disease-causing genotypes show potential for accelerating cell therapy research and industrialization.
Amerigo Scientific's catalog includes more than 10 kinds of iPSC-derived cell products and supporting reagents, covering cell types for neuroscience, vascular research, and disease modeling. The range features BrainFast Neuronal Maturation Supplement, human iPSC-derived spinal motor neurons, spinal astrocytes, mixed cortical neurons, midbrain dopaminergic neurons, microglia, medium spiny GABAergic neurons, and endothelial cells. All products are offered in standardized specifications with cell sources and pricing, ensuring reliable and traceable supply.
With outstanding performance and diverse selections, Amerigo Scientific's iPSC-derived cell products are poised to facilitate deeper exploration of disease pathogenesis, accelerate new drug discovery and toxicity assessment, and drive global cell therapy research.
